LuceBR, ElixhauserAStandards for the Socioeconomic Evaluation of Health Care Services.Berlin: Springer Verlag,1990.
2.
BantaHD, LuceBRHealth Care Technology and its Assessment. An International Perspective.Oxford: Oxford Medical Publications,1993.
3.
DrummondMF, StoddardGL, TorranceGWMethods for the Economic Evaluation of Health Care Programmes.Oxford: Oxford Medical Publications,1987.
4.
WeberBL. Clinical implications of basic research: susceptibility genes for breast cancer.N Engl J Med1994; 331: 1523–4.
5.
HammCW. New serum markers for acute myocardial infarction.N Engl J Med1994; 331: 607–8.
6.
PuleoPR, MeyerD, WathenC, TawaCB, WheelerS, HamburgRJ, AliN, ObermuellerSD, TrianaJF, ZimmermannJL, PerrymanB, RobertsR.Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out myocardial infarction.N Engl J Med1994; 331: 561–6.
7.
NaberSP. Molecular medicine—detection of neoplasia.N Engl J Med1994; 331: 1508–10.
8.
Borch-JohnsenK, WenzelH, VibertiGC, MogensenCE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?BMJ1993; 306: 1722–3.
9.
ArevaloJA, WashingtonAE. Cost-effectiveness of prenatal screening and immunisation for hepatitis B virus.JAMA1988; 259: 365–9.
10.
DestacheCJ. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.Therap Drug Monitoring1990; 12: 419–26.